The Burden of Caring for Individuals with Tuberous Sclerosis Complex (TSC) Who Experience Epileptic Seizures: A Descriptive UK Survey
Authors:
Open Access
- 9 February 2023
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics - Open
- Vol. 7 (2) , 299-312
Abstract
Introduction Tuberous sclerosis complex (TSC) is a rare multisystem genetic condition characterised by benign tumours; prevalent manifestations include epilepsy and neuropsychiatric disorders. This study examined the burden of TSC for primary caregivers and families, exploring the impact of characteristics such as seizures. Methods Primary caregivers of individuals with TSC in the United Kingdom participated in an online survey, comprising the Pediatric Quality of Life Inventory™ Family Impact Module, Hospital Anxiety and Depression Scale (HADS), and TSC-specific items. Responses were analysed using descriptive and regression analysis statistics (closed-ended) or qualitative content analysis (open-ended). Results Seventy-three participants partially completed and 59 fully completed the survey; 95% were female, and 90% were parents of an individual with TSC. A median (range) of 2 (1–11) household members were carers. Primary caregivers spent a mean (standard deviation [SD]) of 104.3 (51.7) hours caring in the previous week, reporting high mean (SD) HADS scores of 11.2 (4.8) (anxiety) and 7.9 (4.4) (depression) and considerable family burden. Increased seizure frequency increased hours spent caring by primary caregivers (p = 0.01) and was associated with a decreased mean (SD) family functioning score of 46.2 (23.0) and parent health-related quality of life (HRQL) score of 45.4 (20.3) (both p = 0.03). Multivariable models predicted intellectual disability increased hours spent caring by primary caregivers (p = 0.01–0.04), and neuropsychiatric comorbidities decreased family functioning (p = 0.02) and caregiver HRQL (p < 0.01). Conclusion These findings highlight the role of epileptic seizures and neuropsychiatric disorders in the considerable burden of TSC on primary caregivers and families.Keywords
Funding Information
- GW Pharmaceuticals, now a part of Jazz Pharmaceuticals, Inc.
This publication has 42 references indexed in Scilit:
- Burden of disease and unmet needs in tuberous sclerosis complex with neurological manifestations: systematic reviewCurrent Medical Research and Opinion, 2011
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous SclerosisNew England Journal of Medicine, 2010
- Epilepsy surgery in tuberous sclerosis complex: Emphasis on surgical candidate and neuropsychologyEpilepsia, 2010
- The Impact of Pediatric Chronic Pain on Parents' Health-Related Quality of Life and Family Functioning: Reliability and Validity of the PedsQL 4.0 Family Impact ModuleJournal of Pediatric Psychology, 2009
- Quality of life, health satisfaction and family impact on caregivers of children with developmental delaysChild: Care, Health and Development, 2009
- Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern IrelandDevelopmental Medicine & Child Neurology, 2007
- An epidemiological study of renal pathology in tuberous sclerosis complexBJU International, 2004
- Prevalence of tuberous sclerosis estimated by capture-recapture analysisThe Lancet, 1998
- MORBIDITY ASSOCIATED WITH TUBEROUS SCLEROSIS: A POPULATION STUDYDevelopmental Medicine & Child Neurology, 1996
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983